ARTICLE | Clinical News
Organon to begin schizophrenia Phase II
September 18, 2001 7:00 AM UTC
Organon (Oss, the Netherlands) will begin a Phase II trial of Ampakine Org 24448, a modulator of the AMPA neurotransmitter receptor, to treat schizophrenia. Organon's decision to continue development ...